The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here ...

The reformulated vaccine defends against new omicron strains, including XBB omicron variants. The panel stopped short of ...

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

Once adopted by the FDA and Centers for Disease Control and Prevention, the change could effectively end use of the original ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

It's part of a plan to offer a single booster to the public each year that gives protection against the most recent, dominant ...

The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine.

In a recent briefing document published by the United States Food and Drug Administration (US-FDA) ahead of an advisory ...

The advisory panel mostly agreed with the FDA ... kids of immigrants COVID-19 vaccines have saved millions of lives and ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...